Cite
MBP-11901 Inhibits Tumor Growth of Hepatocellular Carcinoma through Multitargeted Inhibition of Receptor Tyrosine Kinases.
MLA
Park, Hyun Jin, et al. “MBP-11901 Inhibits Tumor Growth of Hepatocellular Carcinoma through Multitargeted Inhibition of Receptor Tyrosine Kinases.” Cancers, vol. 14, no. 8, Apr. 2022, p. 1994. EBSCOhost, https://doi.org/10.3390/cancers14081994.
APA
Park, H. J., Choi, G., Ha, S., Kim, Y., Choi, M.-J., Kim, M., Islam, M. K., Chang, Y., Kwon, T.-J., Kim, D., Jang, E., Kim, T. H., Chang, S. J., & Kim, Y.-H. (2022). MBP-11901 Inhibits Tumor Growth of Hepatocellular Carcinoma through Multitargeted Inhibition of Receptor Tyrosine Kinases. Cancers, 14(8), 1994. https://doi.org/10.3390/cancers14081994
Chicago
Park, Hyun Jin, Garam Choi, Seongmin Ha, Yesl Kim, Min-Jin Choi, Minsup Kim, Md. Kamrul Islam, et al. 2022. “MBP-11901 Inhibits Tumor Growth of Hepatocellular Carcinoma through Multitargeted Inhibition of Receptor Tyrosine Kinases.” Cancers 14 (8): 1994. doi:10.3390/cancers14081994.